GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (FRA:24C) » Definitions » DeferredTaxAndRevenue

C-Rad AB (FRA:24C) DeferredTaxAndRevenue : €0.00 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is C-Rad AB DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

C-Rad AB's current deferred tax and revenue for the quarter that ended in Mar. 2025 was €0.00 Mil.

C-Rad AB DeferredTaxAndRevenue Historical Data

The historical data trend for C-Rad AB's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB DeferredTaxAndRevenue Chart

C-Rad AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

C-Rad AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

C-Rad AB DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of C-Rad AB's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB Business Description

Traded in Other Exchanges
Address
Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.

C-Rad AB Headlines

No Headlines